Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

[A histological and immunohistological study of vascular and inflammatory changes in rosacea].

Perrigouard C, Peltre B, Cribier B.

Ann Dermatol Venereol. 2013 Jan;140(1):21-9. doi: 10.1016/j.annder.2012.10.592. French.

PMID:
23328356
2.

Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link.

Forton FM.

J Eur Acad Dermatol Venereol. 2012 Jan;26(1):19-28. doi: 10.1111/j.1468-3083.2011.04310.x. Review.

PMID:
22017468
3.

The enigma of rosacea.

Marks R.

J Dermatolog Treat. 2007;18(6):326-8. Review.

PMID:
18058493
4.

The molecular pathology of rosacea.

Yamasaki K, Gallo RL.

J Dermatol Sci. 2009 Aug;55(2):77-81. doi: 10.1016/j.jdermsci.2009.04.007. Review.

5.

Rosacea under the microscope: characteristic histological findings.

Cribier B.

J Eur Acad Dermatol Venereol. 2013 Nov;27(11):1336-43. doi: 10.1111/jdv.12121. Review.

PMID:
23451732
6.
7.

[Current insights into the pathophysiology of rosacea].

Schauber J, Homey B, Steinhoff M.

Hautarzt. 2013 Jul;64(7):481-8. doi: 10.1007/s00105-012-2516-7. Review. German.

PMID:
23760500
8.
9.

Microvenular hemangioma presenting with numerous bilateral macules, patches, and plaques: a case report and review of the literature.

Linos K, Csaposs J, Carlson JA.

Am J Dermatopathol. 2013 Feb;35(1):98-101. doi: 10.1097/DAD.0b013e318259944a. Review.

PMID:
22722465
10.

Clinical, cellular, and molecular aspects in the pathophysiology of rosacea.

Steinhoff M, Buddenkotte J, Aubert J, Sulk M, Novak P, Schwab VD, Mess C, Cevikbas F, Rivier M, Carlavan I, Déret S, Rosignoli C, Metze D, Luger TA, Voegel JJ.

J Investig Dermatol Symp Proc. 2011 Dec;15(1):2-11. doi: 10.1038/jidsymp.2011.7. Review.

11.

An evaluation of potential correlations between pathophysiologic mechanisms, clinical manifestations, and management of rosacea.

Del Rosso JQ, Gallo RL, Tanghetti E, Webster G, Thiboutot D.

Cutis. 2013 Mar;91(3 Suppl):1-8. Review.

PMID:
23833998
12.

The role of altered cutaneous immune responses in the induction and persistence of rosacea.

Margalit A, Kowalczyk MJ, Żaba R, Kavanagh K.

J Dermatol Sci. 2016 Apr;82(1):3-8. doi: 10.1016/j.jdermsci.2015.12.006. Review.

PMID:
26747056
13.

Primary and secondary intralymphatic histiocytosis.

Bakr F, Webber N, Fassihi H, Swale V, Lewis F, Rytina E, Ben-Zvi GT, Norris P, Espinosa O, Dhar S, Craig P, Robson A.

J Am Acad Dermatol. 2014 May;70(5):927-33. doi: 10.1016/j.jaad.2013.11.024. Review.

PMID:
24440319
14.

Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors.

Two AM, Wu W, Gallo RL, Hata TR.

J Am Acad Dermatol. 2015 May;72(5):749-58; quiz 759-60. doi: 10.1016/j.jaad.2014.08.028. Review.

PMID:
25890455
15.

Mast cell modulation of the vascular and lymphatic endothelium.

Kunder CA, St John AL, Abraham SN.

Blood. 2011 Nov 17;118(20):5383-93. doi: 10.1182/blood-2011-07-358432. Review.

16.

Rosacea: The cytokine and chemokine network.

Gerber PA, Buhren BA, Steinhoff M, Homey B.

J Investig Dermatol Symp Proc. 2011 Dec;15(1):40-7. doi: 10.1038/jidsymp.2011.9. Review.

18.

Rosacea as a disease of cathelicidins and skin innate immunity.

Yamasaki K, Gallo RL.

J Investig Dermatol Symp Proc. 2011 Dec;15(1):12-5. doi: 10.1038/jidsymp.2011.4. Review.

19.

Rosacea as an inflammatory disorder: a unifying theory?

Millikan LE.

Cutis. 2004 Jan;73(1 Suppl):5-8. Review.

PMID:
14959939
Items per page

Supplemental Content

Support Center